A
Agamatrix
AgaMatrix develops and manufactures a line of diabetes products designed to improve the quality of diabetes care
About Agamatrix
AgaMatrix specializes in designing, developing, and manufacturing advanced products for diabetes care. The company operates in the healthcare market, focusing on providing reliable and affordable solutions for diabetes management. Its core products include glucose meters, test strips, and lancing devices, all of which are designed to offer high accuracy and ease of use. AgaMatrix serves a diverse range of clients, including individual patients managing their diabetes and healthcare providers seeking dependable tools for patient care. The business model revolves around the sale of these medical devices and accessories, generating revenue through direct sales to consumers and partnerships with healthcare institutions. By leveraging its proprietary WaveSense technology, AgaMatrix ensures that its products deliver consistent and precise results, meeting the high standards demanded by the market. The company aims to make diabetes management more accessible and effective, thereby improving the quality of life for its users.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2001
- Headquarters
- Salem, United States
- Employees
- 80
- Open positions
- 1
- Dealroom signal
- 64.9/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Personal Health, Diabetes, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Technology
- Mobile app
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Agamatrix.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Jul 2019 | $56M | — | Perceptive Advisors | — |
| DEBT✓Debt | Oct 2017 | $32M | — | Prospect Capital Corporation · Prospect Capital Corporation | — |
Growth signals
Latest recorded traffic for Agamatrix is 3.5K monthly website visits, down 30% over the last three months. Agamatrix's team declined 10.1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Tank Partners
Collaborative Fund
Series B and later2 investors entered at this stage
Prospect Capital Corporation
Perceptive Advisors
Other known investors4 additional known investors
University of Cambridge
University of Illinois Urbana Champaign
Hong Kong Science & Technology Parks Corporation
Karl Ruping
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Agamatrix on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Agamatrix’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.